Feyza Kargın
Feyza Kargın has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Cuneyt Salturk
Department of Chest Diseases, Medipol University Faculty of Medicine, İstanbul, Türkiye
3 shared publications - Gökay Güngör
Intensive Care Unit, University of Health Sciences, Sureyyapasa Pulmonary Disease and Pulmonary Surgery Training and Research Hospital, 34844 Istanbul, Türkiye
3 shared publications - Huriye Berk Takir
Clinics of Chest Diseases, University of Health Sciences, Istanbul Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey
3 shared publications - Merih Balcı
Respiratory and Intensive Care Unit, Sureyyapaşa Chest Diseases and Thoracic Surgery Training and Research Hospital, Soyak Yenişehir Manolya Evleri, 34770 Umraniye, Istanbul, Turkey
3 shared publications - Nalan Adıgüzel
Respiratory Intensive Care Unit, Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey
3 shared publications - Zuhal Karakurt
Department of Pulmonology, Süreyyapasa Pulmonary Disease and Pulmonary Surgery Training and Research Hospital, University of Health Sciences, İstanbul, Turkey
3 shared publications
Latest Publications
- Open Access
- 1 January 2014
- Published by Mattioli1885 in Multidisciplinary Respiratory Medicine
- Vol. 9 (1) , 8
The safety of beta-blocker use in chronic obstructive pulmonary disease patients with respiratory failure in the intensive care unit
The safety of beta-blockers as a heart rate-limiting drug (HRLD) in patients with acute respiratory failure (ARF) due to chronic obstructive lung disease (COPD) has not been properly assessed in the intensive care unit (ICU) setting. This study aims to compare the use of beta-blocker drugs relative to non-beta-blocker ones in COPD patients with ARF due to heart rate-limiting with respect to length of ICU stay and mortality.
- 1 January 2014
- Published by Mattioli1885 in Multidisciplinary Respiratory Medicine
- Vol. 9 (1) , 8
Open AccessThe safety of beta-blocker use in chronic obstructive pulmonary disease patients with respiratory failure in the intensive care unit
The safety of beta-blockers as a heart rate-limiting drug (HRLD) in patients with acute respiratory failure (ARF) due to chronic obstructive lung disease (COPD) has not been properly assessed in the intensive care unit (ICU) setting. This study aims to compare the use of beta-blocker drugs relative to non-beta-blocker ones in COPD patients with ARF due to heart rate-limiting with respect to length of ICU stay and mortality.
- Open Access
- 1 January 2012
- Published by Mattioli1885 in Multidisciplinary Respiratory Medicine
- Vol. 7 (1) , 47
C-reactive protein as a predictor of mortality in patients affected with severe sepsis in intensive care unit
Severe sepsis is a primary cause of morbidity and mortality in the intensive care unit (ICU). Numerous biomarkers have been assessed to predict outcome and CRP is widely used. However, the relevance for mortality risk of the CRP level and the day when it is measured have not been well studied. We aimed to assess whether initial and/or third dayCRP values are as good predictors of mortality in ICU patients with severe sepsis as other well-known complex predictors of mortality, i.e., SOFA scores.
- 1 January 2012
- Published by Mattioli1885 in Multidisciplinary Respiratory Medicine
- Vol. 7 (1) , 47
Open AccessC-reactive protein as a predictor of mortality in patients affected with severe sepsis in intensive care unit
Severe sepsis is a primary cause of morbidity and mortality in the intensive care unit (ICU). Numerous biomarkers have been assessed to predict outcome and CRP is widely used. However, the relevance for mortality risk of the CRP level and the day when it is measured have not been well studied. We aimed to assess whether initial and/or third dayCRP values are as good predictors of mortality in ICU patients with severe sepsis as other well-known complex predictors of mortality, i.e., SOFA scores.
- Open Access
- 1 January 2012
- Published by Mattioli1885 in Multidisciplinary Respiratory Medicine
- Vol. 7 (1) , 30
Management of kyphoscoliosis patients with respiratory failure in the intensive care unit and during long term follow up
We aimed to evaluate the ICU management and long-term outcomes of kyphoscoliosis patients with respiratory failure.
- 1 January 2012
- Published by Mattioli1885 in Multidisciplinary Respiratory Medicine
- Vol. 7 (1) , 30
Open AccessManagement of kyphoscoliosis patients with respiratory failure in the intensive care unit and during long term follow up
We aimed to evaluate the ICU management and long-term outcomes of kyphoscoliosis patients with respiratory failure.